KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Change in Accured Expenses (2019 - 2025)

Hims & Hers Health's Change in Accured Expenses history spans 7 years, with the latest figure at -$1.9 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 119.48% year-over-year to -$1.9 million; the TTM value through Dec 2025 reached -$43.1 million, down 280.96%, while the annual FY2025 figure was -$43.1 million, 280.96% down from the prior year.
  • Change in Accured Expenses for Q4 2025 was -$1.9 million at Hims & Hers Health, up from -$52.9 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $14.0 million in Q3 2024 and bottomed at -$52.9 million in Q3 2025.
  • The 5-year median for Change in Accured Expenses is $2.0 million (2023), against an average of -$81600.0.
  • The largest YoY upside for Change in Accured Expenses was 724.54% in 2021 against a maximum downside of 1662.99% in 2021.
  • A 5-year view of Change in Accured Expenses shows it stood at $991000.0 in 2021, then crashed by 565.29% to -$4.6 million in 2022, then skyrocketed by 134.96% to $1.6 million in 2023, then surged by 507.26% to $9.8 million in 2024, then plummeted by 119.48% to -$1.9 million in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Change in Accured Expenses are -$1.9 million (Q4 2025), -$52.9 million (Q3 2025), and $7.4 million (Q2 2025).